24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Blood Cancer
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:43
Full list of Israeli high-tech layoffs in 2026
17:30
After raising $20 million, collapsed startup Swish.ai sells to Unframe for just $150,000
17:00
Artlist to cut 200 jobs, 40% of workforce, in AI-driven overhaul
16:34
Full list of Israeli high-tech funding rounds in 2026
More stories
Buzz
Most popular
Daily
Weekly
1
Jewish family from Mexico donates NIS 200 million to establish Israel's largest rehabilitation hospital
2
After raising $20 million, collapsed startup Swish.ai sells to Unframe for just $150,000
3
Echo: “Employees have become very good at identifying performative culture”
4
1Password acquires Israeli cyber startup Apono in $250M-$300M deal
5
SailPoint acquires Israeli cyber startup Entro Security in $200 million deal
More news
Blood Cancer
4 stories about Blood Cancer
Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals
24.12.18
|
Lilach Baumer
The investment is part of a licensing option agreement signed between the two companies
Scientist’s Ex-Wife Joins Legal Melee Over Kite Pharma Windfall
16.01.18
|
Zohar Shahar Levy
Zelig Eshhar, the patent holder for Kite Pharma’s anti-cancer technology, is currently being sued by a former student for infringement of patent rights
Pharma Veteran Julian Adams takes Helm at Gamida Cell
21.11.17
|
Lilach Baumer
The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor
Kite Pharma’s Cancer Drug Gets Regulatory Nod
19.10.17
|
Lilach Baumer
The cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000